{"DataElement":{"publicId":"3320073","version":"1","preferredName":"Minor Component Malignant Neoplasm Intratumoral Heterogeneity Nuclear Pleomorphism Score Category","preferredDefinition":"Numeric percentage and score to describe the nuclear pleomorphism of a minor component with intratumoral morphologic heterogeneity characteristics.","longName":"3320066v1.0:3316561v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3320066","version":"1","preferredName":"Minor Element Malignant Neoplasm Intratumoral Heterogeneity Nuclear Pleomorphism Assessment","preferredDefinition":"Lesser or smaller in amount, extent, or size._An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004 _Within a tumor._The quality or state of consisting of elements that are not of the same kind or nature._Having nuclei with various distinct forms._The final result of a determination of the value, significance, or extent of.","longName":"3320057v1.0:3320064v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3320057","version":"1","preferredName":"Minor Element Malignant Neoplasm","preferredDefinition":"Lesser or smaller in amount, extent, or size.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C45367:C48792:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minor","conceptCode":"C45367","definition":"Lesser or smaller in amount, extent, or size.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Element","conceptCode":"C48792","definition":"An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31CE3A1-C663-30FC-E040-BB89AD433C21","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3320064","version":"1","preferredName":"Intratumoral Heterogeneous Nuclear Pleomorphism Assessment","preferredDefinition":"Within a tumor.:The quality or state of consisting of elements that are not of the same kind or nature.:Having nuclei with various distinct forms.:The final result of a determination of the value, significance, or extent of.","longName":"C28036:C28359:C38721:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intratumoral","conceptCode":"C28036","definition":"Within a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Heterogeneity","conceptCode":"C28359","definition":"The quality or state of consisting of elements that are not of the same kind or nature.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Nuclear Pleomorphism","conceptCode":"C38721","definition":"Having nuclei with various distinct forms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-AAF4-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-AB05-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3316561","version":"1","preferredName":"Nuclear Pleomorphism Score Category","preferredDefinition":"Having nuclei with various distinct forms._A number or range of numeric values measuring performance, function, quality, or ability._Category; used informally to mean a class of things.","longName":"3316561v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"31","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"not applicable (no minor compenent)","valueDescription":"None or Not Applicable","ValueMeaning":{"publicId":"3320040","version":"1","preferredName":"None or Not Applicable","longName":"3320040","preferredDefinition":"A term used to indicate that information on a specific question or subject can not be provided because there is no relevance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None or Not Applicable","conceptCode":"C18902","definition":"A term used to indicate that information on a specific question or subject can not be provided because there is no relevance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31C90A0-F6E7-977D-E040-BB89AD4330E1","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B31C90A0-F715-977D-E040-BB89AD4330E1","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","deletedIndicator":"No"},{"value":"score cannot be determined (NA)","valueDescription":"score cannot be determined (NA)","ValueMeaning":{"publicId":"3316556","version":"1","preferredName":"score cannot be determined (NA)","longName":"3316556","preferredDefinition":"score cannot be determined (NA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6048-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-610C-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"chromatin clumping (score = 3)","valueDescription":"chromatin clumping (score = 3)","ValueMeaning":{"publicId":"3316562","version":"1","preferredName":"chromatin clumping (score = 3)","longName":"3316562","preferredDefinition":"chromatin clumping (score = 3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6116-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-612F-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"marked variation in size, prominent nucleoli","valueDescription":"marked variation in size, prominent nucleoli","ValueMeaning":{"publicId":"3316563","version":"1","preferredName":"marked variation in size, prominent nucleoli","longName":"3316563","preferredDefinition":"marked variation in size, prominent nucleoli","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6139-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-6152-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"moderate increase in size (score = 2)","valueDescription":"moderate increase in size (score = 2)","ValueMeaning":{"publicId":"3316564","version":"1","preferredName":"moderate increase in size (score = 2)","longName":"3316564","preferredDefinition":"moderate increase in size (score = 2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-615C-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-6175-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"small regular nuclei (score = 1)","valueDescription":"small regular nuclei (score = 1)","ValueMeaning":{"publicId":"3316565","version":"1","preferredName":"small regular nuclei (score = 1)","longName":"3316565","preferredDefinition":"small regular nuclei (score = 1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-617F-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-6198-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3316560","version":"1","preferredName":"Nuclear Pleomorphism Score Category","preferredDefinition":"Having nuclei with various distinct forms.:A number or range of numeric values measuring performance, function, quality, or ability.:Category; used informally to mean a class of things.","longName":"C38721:C25338:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear Pleomorphism","conceptCode":"C38721","definition":"Having nuclei with various distinct forms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-60E4-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-60F5-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"COOPERM","dateModified":"2011-12-14","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Nuclear pleomorphism of minor","type":"Preferred Question Text","description":"Nuclear pleomorphism of minor component in cases with intratumoral heterogeneity","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-ABDD-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}